Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Datopotamab deruxtecan

Catalog No. T39730Cas No. 2238831-60-0
Alias S-1062a, DS-1062, DS1062, Dato-DXd

Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2)-targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.

Datopotamab deruxtecan

Datopotamab deruxtecan

Catalog No. T39730Alias S-1062a, DS-1062, DS1062, Dato-DXdCas No. 2238831-60-0
Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2)-targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.
Pack SizePriceAvailabilityQuantity
1 mg$1,060In Stock
5 mg$3,150In Stock
Bulk & Custom
Add to Cart
Questions
View More
Select Batch
Concentration:4.04 mg/mL
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Datopotamab deruxtecan (DS-1062) is a trophoblast cell surface antigen 2 (TROP2)-targeted antibody-drug conjugate (ADC) with antitumor activity. Datopotamab deruxtecan induces significant antibody-dependent cellular cytotoxicity in the presence of peripheral blood lymphocytes and inhibits tumor growth in xenograft models.
In vitro
Datopotamab deruxtecan specifically binds to TROP2. 100 μg/mL Datopotamab deruxtecan is internalized into the tumor cell and reaches the lysosome via the intracellular transport pathway and releases Deruxtecan. In vitro experiments Datopotamab deruxtecan caused DNA damage and triggered apoptosis in tumor cells expressing TROP2. [1]
In vivo
Datopotamab deruxtecan exhibited significant antitumor activity in a variety of TROP2-expressing xenograft tumors, and 6 mg/kg Datopotamab deruxtecan treatment of a patient-derived xenograft (PDX) model of non-small-cell lung cancer (NSCLC) induced tumor regression. In addition, Datopotamab deruxtecan has an acceptable safety profile in rats and crab-eating monkeys. [1]
AliasS-1062a, DS-1062, DS1062, Dato-DXd
Chemical Properties
Cas No.2238831-60-0
Storage & Solubility Information
Storagestore at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Datopotamab deruxtecan | purchase Datopotamab deruxtecan | Datopotamab deruxtecan cost | order Datopotamab deruxtecan | Datopotamab deruxtecan chemical structure | Datopotamab deruxtecan in vivo | Datopotamab deruxtecan in vitro